Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Pylera with omeprazole for treating helicobacter pylori associated ulcers	Omeprazole (Yosprala;PA32540;Omeprazole magnesium;Omeprazole sodium , Pylera (BLI-1300;FP-110;Metronidazole benzoate)	Helicobacter pylori	Gastroenterology	2023	View \| Download
Quizartinib with chemotherapy for FLT3-ITD positive acute myeloid leukaemia	Quizartinib (AC220)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2021	View \| Download
rAAVrh74.MHCK7.micro-dystrophin for Duchenne muscular dystrophy	Microdystrophin (SRP-9001; rAAVrh74.MHCK7)	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2020	View \| Download
Ramucirumab (Cyramza) + capecitabine or 5-FU + cisplatin for gastric cancer of GOJ – treatment naive for palliative chemotherapy	5-Fluorouracil , Capecitabine (Xeloda) , Cisplatin (Platinol) , Ramucirumab (Cyramza)	Gastro-oesophageal junction cancer	Gastrointestinal Cancer	2017	View \| Download
Ramucirumab for Advanced Hepatocellular Carcinoma – second line	Ramucirumab (Cyramza)	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2018	View \| Download
Ramucirumab in addition to erlotinib for EGFR mutation-positive metastatic non-small-cell lung cancer	Erlotinib (Tarceva; erlotinib hydrochloride) , Ramucirumab (Cyramza)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2019	View \| Download
Ranibizumab Biosimilar for Age-related Macular Degeneration	Ranibizumab biosimilar (FYB201; BI695511; PF582; QL1205; Xlucane; SB11)	Age-related macular degeneration (AMD)	Ophthalmology	2021	View \| Download
Ranibizumab for proliferative and non-proliferative diabetic retinopathy	Ranibizumab (Lucentis Port Delivery System; Lucentis)	Diabetic retinopathy	Endocrine Nutritional and Metabolic Disorders , Ophthalmology	2018	View \| Download
Ranibizumab for Retinopathy of Prematurity – first line	Ranibizumab (Lucentis Port Delivery System; Lucentis)	Retinopathy of prematurity	Gynaecology and Obstetrics , Ophthalmology	2018	View \| Download
Ranibizumab port delivery system for the treatment of age-related macular degeneration	Ranibizumab (Lucentis Port Delivery System; Lucentis)	Age-related macular degeneration (AMD)	Ophthalmology	2020	View \| Download